Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Syndrome

1-methyl-3-isobutylxanthine has been researched along with Syndrome in 2 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Syndrome: A characteristic symptom complex.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lu, C1
Pribanic, S1
Debonneville, A1
Jiang, C1
Rotin, D1
Hopf, A1
Schreiber, R1
Mall, M1
Greger, R1
Kunzelmann, K1

Other Studies

2 other studies available for 1-methyl-3-isobutylxanthine and Syndrome

ArticleYear
The PY motif of ENaC, mutated in Liddle syndrome, regulates channel internalization, sorting and mobilization from subapical pool.
    Traffic (Copenhagen, Denmark), 2007, Volume: 8, Issue:9

    Topics: 1-Methyl-3-isobutylxanthine; Amino Acid Motifs; Animals; Cell Line; Cell Membrane; Cyclic AMP; Endoc

2007
Cystic fibrosis transmembrane conductance regulator inhibits epithelial Na+ channels carrying Liddle's syndrome mutations.
    The Journal of biological chemistry, 1999, May-14, Volume: 274, Issue:20

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Antibodies; Calcium-Binding Proteins; Cyclic AMP-Dependent Pro

1999